Major hepatectomy for colorectal metastases: Is preoperative portal occlusion an oncological risk factor?

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1908-1917

  Mueller, L ^a,b   Hillert, C ^a   Moller L ^a   Krupski Berdien, G ^a,c   Rogiers, X ^d   Broering, D C ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Hospital Reinbek St Adolf Stift   (Germany)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Complication rate; Hepatic resection; Liver metastasis; Portal ligation; Portal vein embolization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PORTAL VEIN OBSTRUCTION; RISK BENEFIT ANALYSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIGATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; PORTAL VEIN; PREOPERATIVE CARE; RISK FACTORS;

EID: 46149102669     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9925-y     Document Type: Article

References (34)

1. Vauthey JN, Pawlik TM, Abdalla EK. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239:722-32
2. Capussotti L, Muratore A, Mulas MM, et al. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 2006; 93:1001-6
3. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005; 23:8490-9
4. Broering DC, Hillert C, Krupski G, et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6:905-13
5. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237:686-91
6. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237:208-17
7. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16:779-90
8. Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007; 31:367-74
9. Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94:1386-94
10. Oussoultzoglou E, Bachellier P, Rosso E, et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg 2006; 244:71-9
11. Elias D, De Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86:784-88
12. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34:267-72
13. Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or = 0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 2007; 204:22-33
14. Chun YS, Ribero D, Abdalla EK, et al. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 2008; 12:123-8
15. Barbaro B, Di Stasi C, Nuzzo G, et al. Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 2003; 44:98-102
16. Kollmar O, Corsten M, Scheuer C, et al. Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1534-42
17. Mueller L, Goettsche J, Abdulgawad A, et al. Tumor growth-promoting cellular host response during liver atrophy after portal occlusion. Liver Int 2005; 25:994-1001
18. Lindner P, Cahlin C, Friman S, et al. Extended right-sided liver resection for colorectal liver metastases-impact of percutaneous portal venous embolisation. Eur J Surg Oncol 2006; 32:292-6
19. Tanaka K, Shimada H, Ueda M, et al. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol 2007; 14:1336-46
20. Stewart GD, O'Súilleabháin CB, Madhavan KK, et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004; 30:370-6
21. Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12:297-303
22. Wilms C, Mueller L, Lenk C, et al. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247:825-34
23. Tsuchiya Y, Sawada S, Yoshioka I, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133:547-55
24. Aalbers AG, ten Kate M, van Grevenstein WM, et al. A small mammal model of tumour implantation, dissemination and growth factor expression after partial hepatectomy. Eur J Surg Oncol 2008; 34:469-75
25. Capussotti L, Muratore A, Ferrero A, et al. Extension of right portal vein embolization to segment IV portal branches. Arch Surg 2005; 140:1100-3
26. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24:4983-90
27. Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94:274-86
28. Sigurdson ER, Ridge JA, Kemeny N, et al. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987; 5:1836-40
29. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243:1-7
30. Elias D, Lasser P, Rougier P, et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180:213-9
31. King PD, Perry MC. Hepatotoxicity of chemotherapy. Oncologist 2001; 6:162-76
32. Goéré D, Farges O, Leporrier J, et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 2006; 10:365-70
33. Beal IK, Anthony S, Papadopoulou A, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 2006; 79:473-8
34. Selzner N, Pestalozzi BC, Kadry Z, et al. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J Surg 2006; 93:587-92